Clinical Trial Update: Icaritin in Combination With AG in Patients With Previously Untreated Advanced Pancreatic Ductal Adenocarcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating Icaritin in combination with AG for previously untreated advanced pancreatic ductal adenocarcinoma and is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• AG
• Icaritin (icaritin)

Snippet

Sponsor: Sir Run Run Shaw Hospital | Conditions: Advanced Pancreatic Ductal Adenocarcinoma | Phase 2 | Status: RECRUITING